Veracyte Inc.
VCYT | NASDAQ
$41.52
+$1.73 (+4.33%)
At close: Sep 21, 2026, 4:00 PM ET
$41.54
+$0.02 (+0.05%)
Pre-market:
Sep 22, 2026, 6:07 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 517.15M | 445.76M | 361.05M | 296.54M | 219.51M | 117.48M |
Cost of Revenue | 157.1M | 147.62M | 112.9M | 101.58M | 74.4M | 41.46M |
Gross Profit | 360.05M | 298.15M | 248.15M | 194.95M | 145.11M | 76.03M |
Operating Income | 74.15M | 16.14M | -85.8M | -41.08M | -81.9M | -35.39M |
Interest Income | n/a | 11.15M | 7.34M | 1.97M | 135K | 594K |
Pretax Income | 68.2M | 25.74M | -76.61M | -36.43M | -81.65M | -34.91M |
Net Income | 66.35M | 24.14M | -74.4M | -36.56M | -75.56M | -34.91M |
Selling & General & Admin | 210.95M | 206.04M | 184.23M | 174.08M | 181.19M | 89.12M |
Research & Development | 70.81M | 69.29M | 57.31M | 40.6M | 29.84M | 17.2M |
Other Expenses | 4.13M | 6.67M | 92.41M | 21.35M | 15.98M | 5.1M |
Operating Expenses | 285.9M | 282M | 333.94M | 236.04M | 227.02M | 111.42M |
Interest Expense | n/a | 2K | 15K | 198K | 241K | 229K |
Selling & Marketing Expenses | 100.17M | 27.77M | 26.6M | 97.56M | 79.84M | 52.39M |
Cost & Expenses | 443M | 429.62M | 446.85M | 337.62M | 301.42M | 152.87M |
Income Tax Expense | 1.85M | 1.61M | -2.21M | 133K | -6.09M | n/a |
Shares Outstanding (Basic) | 78.58M | 76.48M | 72.64M | 71.55M | 67.89M | 53.24M |
Shares Outstanding (Diluted) | 80.57M | 78.16M | 72.64M | 71.55M | 67.89M | 53.24M |
EPS (Basic) | 0.84 | 0.32 | -1.02 | -0.51 | -1.11 | -0.66 |
EPS (Diluted) | 0.82 | 0.31 | -1.02 | -0.51 | -1.11 | -0.66 |
EBITDA | 89.62M | 49.21M | -49.41M | -6.98M | -60.18M | -26.74M |
EBIT | 68.2M | 25.75M | -76.6M | -36.23M | -81.41M | -34.68M |
Depreciation & Amortization | 21.42M | 23.46M | 27.19M | 29.25M | 21.23M | 7.94M |
Add to Watchlist
Select watchlists to add or remove VCYT